1 / 11

HIV/AIDS communities and AIDS vaccine research

HIV/AIDS communities and AIDS vaccine research. AIDES / TRT-5 Tour Essor 14, rue Scandicci 93508 Pantin Cedex. Questions from the community. ANRS and vaccine trials of therapeutic vaccines ANRS and recruitment of HIV-volunteers to participate to vaccine trials (safety issues raised)

ross-woodard
Download Presentation

HIV/AIDS communities and AIDS vaccine research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV/AIDS communities and AIDS vaccine research AIDES / TRT-5 Tour Essor 14, rue Scandicci 93508 Pantin Cedex

  2. Questions from the community • ANRS and vaccine trials of therapeutic vaccines • ANRS and recruitment of HIV-volunteers to participate to vaccine trials (safety issues raised) • Partnership with African NGOs (Réseau Afrique 2000): how far are we from a vaccine? • To stop the spread of AIDS

  3. To be better informed • TRT-5 first met • with the ANRS investigators (1999) • Aventis (Alvac) in 1999 • Attendance to scientific meetings • Internal training sessions (immunologists)

  4. To inform(articles in our newsletters)

  5. To inform(training sessions in Africa)

  6. To inform(symposium on immunology)

  7. To inform • Press releases after the announcement of the results of the ANRS trials • Press release after AIDSVAX results

  8. To link up • Vaccine Working Group • IAVI partnership • Microbicides initiative

  9. To work with • ANRS • AC5 Clinical trials: to have two community representatives (voting rights) • AC28 Preventive vaccines: two community representatives (one from the HIV community and one from the volunteers) • Modification of design of clinical trials • Set up of the long term follow up of vaccinees

  10. To lobby • Towards the Industry to have access to vaccine preparation (Aventis supplied Orvéac with ALVAC after a TRT-5 meeting) • Authorities to maintain a strong commitment to prolong the ANRS • Within the ANRS, AC28 to finally do a proper work!

  11. To lobby • Within our organization for preventive technologies to be a priority • EU for commitment • French government to pursue funding for a preventive vaccine. Does it have to be only directed to the ANRS?

More Related